Latest / Pharmacy Podcast Network / Health Security, Specialty Care & the OTC Products Patients Trust | TWIRx
Transcript
- 0:02Speaker 1: We'd like to thank our podcast press sponsor Paragon three
- 0:05Speaker 1: to sixty. Where complex therapies meet personalized care. Paragon three
- 0:12Speaker 1: sixty is an independent specialty pharmacy focused on patients with
- 0:15Speaker 1: rare and complex conditions, delivering a high level of care
- 0:18Speaker 1: through advanced technology and one on one clinical support. Unlike
- 0:22Speaker 1: traditional models, Paragon builds strong relationships with patients, providers, and
- 0:27Speaker 1: healthcare teams, acting as an extension of the clinical team
- 0:31Speaker 1: to accelerate time to treatment, improve adherence, and simplify access
- 0:35Speaker 1: to life changing therapies. Through their innovative digital health platform
- 0:39Speaker 1: and adherence programs, Paragon provides real time insights into patient progress,
- 0:44Speaker 1: helping ensure better outcomes while reducing barriers across the treatment
- 0:48Speaker 1: journey from oncology and neurology to rare disease in advanced biologics.
- 0:53Speaker 1: Their expertise, nationwide reach in twenty four to seven clinical
- 0:57Speaker 1: support position them at the forefront of modern specialty pharmacy
- 1:00Speaker 1: care with industry leading patient satisfaction. In a commitment to personalized,
- 1:04Speaker 1: high touch service, Paragon Pharmacy three p sixty is redefining
- 1:08Speaker 1: what it means to support patients with complex conditions. As
- 1:12Speaker 1: we head into Assembia twenty six. Paragon is helping shape
- 1:15Speaker 1: the future of specialty pharmacy, one patient at a time.
- 1:19Speaker 1: To learn more, visit Paragonpharmacy dot org.
- 1:34Speaker 2: You are listening to the global network of podcasters dedicated
- 1:38Speaker 2: to the pharmacy profession.
- 1:39Speaker 3: Welcome to the Pharmacy Podcast.
- 1:41Speaker 2: Network special this Week in Pharmacy feature. And this is
- 2:13Speaker 2: on all of our minds. This isn't just something that
- 2:17Speaker 2: I've come up with. Obviously, Pharmacists out there throughout the
- 2:20Speaker 2: country realize how our world is in a lot of
- 2:26Speaker 2: pain right now with some of the global conference conflicts
- 2:30Speaker 2: that have been taking place. I've talked about Medica Life
- 2:33Speaker 2: a lot on the Pharmacy Podcast Network. We are actually
- 2:38Speaker 2: a podcast that is featured through Medica Life. A shout
- 2:41Speaker 2: out to Gilbash for his direction, and a shout out
- 2:44Speaker 2: to Finn Partners, who's been a wonderful collaborator with me
- 2:48Speaker 2: over the years, a friend of mine who taught me
- 2:52Speaker 2: a lot about the details of global conflict. I'm going
- 2:57Speaker 2: to be featuring today, but I want I'm going to
- 2:59Speaker 2: put this link in the show notes that the title
- 3:01Speaker 2: of this article is the Hidden cost of Global Conflict.
- 3:05Speaker 2: Why health security is the first casualty and this goes
- 3:11Speaker 2: from a first point of view of the relationships that
- 3:16Speaker 2: this author has on an international level, and I want
- 3:20Speaker 2: to go through this today. I would like to welcome
- 3:22Speaker 2: my friend Aman Gupta to the show. And amad it's
- 3:27Speaker 2: been way too long. We should have done this sooner.
- 3:30Speaker 4: We should have Doddan. But thanks a lot for having
- 3:34Speaker 4: me as part of this amazing conversation and I would
- 3:38Speaker 4: sort of say, a most relevant conversation in today's time.
- 3:41Speaker 4: So I'm really excited to be and thankful to you
- 3:46Speaker 4: to sort of, you know, having me as part of
- 3:48Speaker 4: this conversation.
- 3:49Speaker 5: Yes, you know.
- 3:52Speaker 2: There's a funny saying and game that they came up
- 3:57Speaker 2: with about twelve years ago called the Kevin Bacon effect.
- 4:01Speaker 2: And Kevin Bacon is a well known actor in Hollywood,
- 4:04Speaker 2: and they say that everybody's connected to Kevin Bacon within
- 4:08Speaker 2: five or six points of people. And you and I
- 4:12Speaker 2: are closer connected than anything Kevin Bacon could ever do.
- 4:15Speaker 2: So maybe we should say it becomes the Aman Gupta effect.
- 4:21Speaker 5: But you have.
- 4:23Speaker 2: Connections to the pharmacy industry not only in the United
- 4:27Speaker 2: States but also in India, and that's very special to me.
- 4:30Speaker 2: Because I want to cultivate listeners and content that really
- 4:35Speaker 2: shares with eighty five thousand listeners that we've developed for
- 4:39Speaker 2: seventeen years podcasting. So having you talk with our listeners
- 4:44Speaker 2: today about the true impact from your perspective in this
- 4:47Speaker 2: wonderful article that you was very heartfelt, but also it
- 4:50Speaker 2: was jammed with a lot of factual information. Talk to
- 4:55Speaker 2: our listeners, tell them about yourself, tell them where you're
- 4:58Speaker 2: at and where your main home offices are, and then
- 5:02Speaker 2: let's get into this article.
- 5:04Speaker 4: No, thank you, Todd. So I'll try to make it
- 5:07Speaker 4: tech really quick. And I said, I'm based in India
- 5:10Speaker 4: and I started my journey with the pharmacirical industry and
- 5:15Speaker 4: then pivoted to become a health communicator in year two thousand.
- 5:20Speaker 4: So this is the twenty sixth year of being a
- 5:23Speaker 4: health communicator and I believe the role which we play
- 5:26Speaker 4: is very, very critical. Now India is sort of seen
- 5:32Speaker 4: as the pharmacity of the world. You know, we do
- 5:35Speaker 4: supply across more than one hundred and fifteen countries. And
- 5:39Speaker 4: the whole idea is that access to the medicine per
- 5:43Speaker 4: se should be your first rude because nobody should be
- 5:50Speaker 4: living in in ill here, So somebody should not be
- 5:55Speaker 4: living in where the quality of life is kind of
- 5:57Speaker 4: a low. So I think that's kind of a basic
- 6:00Speaker 4: frame wise which exists. And when I was writing this
- 6:04Speaker 4: particular article, it took me back to year two thousand
- 6:09Speaker 4: and one. That was the first time when I met
- 6:14Speaker 4: Professor Jeffrey Sachs. You know, he's one of the global
- 6:17Speaker 4: thought leaders from a health economics perspective, and I was
- 6:23Speaker 4: managing history to India and one of the things which
- 6:26Speaker 4: really stood out for me as as a student of
- 6:30Speaker 4: and that kind of a student for life, is that
- 6:33Speaker 4: how health and economics are interlinked. So when we sort
- 6:37Speaker 4: of talk about anything which impacts health and in this
- 6:41Speaker 4: part and you know, being in you know, with the
- 6:44Speaker 4: West Asia conflict currently kind of you know, going through
- 6:47Speaker 4: and we are more closer to that, we don't see
- 6:52Speaker 4: the layers beyond what might be getting reported into the
- 6:57Speaker 4: media because that's the immediacy over happening. What will follow
- 7:02Speaker 4: through over the course of the next months and the
- 7:05Speaker 4: years is much more larger because what it's done is
- 7:09Speaker 4: that it has pivoted the priorities to something which is
- 7:16Speaker 4: more led by defense, is more led by the conflict.
- 7:20Speaker 4: And when that's how pivoting happens. It allows people to
- 7:27Speaker 4: sort of say, I'm not going to focus on what
- 7:28Speaker 4: is the core, which is the health part of it.
- 7:31Speaker 4: And when health is not given its due priorities, it
- 7:35Speaker 4: will impact the economics, It will impact the people per se,
- 7:42Speaker 4: not just from a physical perspective. Will I back them
- 7:44Speaker 4: from the quality of life there for the mental will
- 7:48Speaker 4: being part of it, and so many other things, and
- 7:50Speaker 4: therefore the overarching perspective of how we as humanity are
- 7:57Speaker 4: living on this planet as to dip down. So the
- 8:01Speaker 4: impact is much more bigger. It's not something that you
- 8:04Speaker 4: can quantify in a dollar value or you know, in
- 8:07Speaker 4: a in a percentage format. It's much more larger. And
- 8:11Speaker 4: that thing will continue to echo post the whole conflict
- 8:16Speaker 4: is done, you know. And that's I think it's a
- 8:20Speaker 4: bigger issue. And why one conflict definuity should be avoided
- 8:25Speaker 4: where if it is kind of possible, but it should
- 8:27Speaker 4: not be allowed to impact the health part of it.
- 8:32Speaker 5: That makes a lot of sense.
- 8:34Speaker 2: I have a sensitive question from you from your opinion
- 8:38Speaker 2: and understanding, why why are Americans so unattached in many
- 8:48Speaker 2: ways from what else is happening in the world and
- 8:53Speaker 2: not understanding that the health and the wellbeing of others
- 8:59Speaker 2: is coming full circle, and it is impacting economies, and
- 9:04Speaker 2: it is impacting the ability to grow and to cultivate
- 9:11Speaker 2: the specialness of one part of our global culture versus another.
- 9:17Speaker 5: And I think we miss it because we get too.
- 9:20Speaker 2: Involved in our iPhones and our tiktoks, and we centralize,
- 9:25Speaker 2: and I almost feel like we're a little bit our
- 9:29Speaker 2: culture is a little bit of a selfish nation in
- 9:32Speaker 2: some ways because we don't understand the interconnection. And you've
- 9:37Speaker 2: had an opportunity to connect to other parts of the world,
- 9:41Speaker 2: bring out the stories through your writings, connect with clients
- 9:44Speaker 2: who are very much relying on you to get the
- 9:47Speaker 2: communications out about what they're doing to help other people.
- 9:51Speaker 2: Talk to us about kind of that dynamic, and is
- 9:55Speaker 2: that part of all humans that kind of centralize and
- 9:58Speaker 2: we forget about each other or do you think like
- 10:01Speaker 2: I actually have a strong opinion, I think the United
- 10:04Speaker 2: States tends to be our culture and our society tends
- 10:07Speaker 2: to be a little bit more selfish.
- 10:10Speaker 4: Okay, So I would not try to I don't think
- 10:13Speaker 4: it's it's a specifically to a job of phase. It's
- 10:16Speaker 4: not just you know, if you say happening in America,
- 10:20Speaker 4: say that they are kind of accilerated from the rest
- 10:25Speaker 4: of the world. It's an aspect and it was something
- 10:30Speaker 4: which I was reading today morning itself. It's an aspect
- 10:34Speaker 4: of privilege versus not privileged. So let's sort of look
- 10:40Speaker 4: at the globe instrutality, right, you have the developed economy,
- 10:48Speaker 4: the emerging economies, and as as we call is the
- 10:53Speaker 4: least developed of nm C is another low and middle
- 10:57Speaker 4: income kind of things. And then of course you can
- 10:58Speaker 4: further down now because there is inequality which exists within
- 11:06Speaker 4: the way the whole economies are doing. It's the people
- 11:11Speaker 4: who reside there. So, as I said, it's not just
- 11:14Speaker 4: something which you will see within say in America, you
- 11:18Speaker 4: will see within economies like India where people who are privileges,
- 11:24Speaker 4: which I figured out today morning. The privilege basically means
- 11:27Speaker 4: I have a private law. So there's a general law
- 11:30Speaker 4: and there's a private law. Privilege comes from the Latin word,
- 11:33Speaker 4: which is prevay law, which is.
- 11:35Speaker 6: My own law.
- 11:36Speaker 4: And I'm thinking from that particular lens. And it's not
- 11:41Speaker 4: something which you would like to put a finger on
- 11:44Speaker 4: somebody saying why you're thinking, but that's how you see
- 11:47Speaker 4: the world. It's it's the lens through which you see
- 11:49Speaker 4: the world. I think the aspect which is very important
- 11:53Speaker 4: is and I think it's it's something which individuals and
- 11:57Speaker 4: the communy communities to think, is that you're not isolated.
- 12:03Speaker 4: The main important aspect is that in produces world, you're
- 12:06Speaker 4: not an isolated country, You're not an asceolated community. Everything
- 12:11Speaker 4: is interconnected and tomorrow of any of this interconnection breaks down,
- 12:17Speaker 4: it will have a direct impact on you. So just
- 12:20Speaker 4: for an example, if we look at it, we know
- 12:23Speaker 4: that China is one of the biggest suppliers of almost
- 12:26Speaker 4: everything across the world, and in a COVID, in a
- 12:31Speaker 4: post covered world and a geopolitical thing, we do know
- 12:34Speaker 4: that if China decides that I would like to isolate myself, it.
- 12:38Speaker 6: Will have an impact forum.
- 12:42Speaker 4: So the interconnectivity becomes very essential. And I think it's
- 12:46Speaker 4: something which thought you and have discussed in the past,
- 12:49Speaker 4: that we need to look at world as an interconnected humanity,
- 12:54Speaker 4: how that connection needs to be seen as a positive,
- 13:00Speaker 4: as a strength, and if we can do that, we
- 13:05Speaker 4: will be in a world where things become so much
- 13:07Speaker 4: easier to exist where the strength of one becomes the
- 13:12Speaker 4: strength of somebody. Is we need to look at our world,
- 13:15Speaker 4: which is much more positive in its thinking. Rather they're
- 13:17Speaker 4: trying to look at the negatives and try to sort
- 13:21Speaker 4: of say that there is a certain kind of a
- 13:24Speaker 4: supermassive which exis so.
- 13:27Speaker 2: Well the global economies, which I'm not sure if my
- 13:33Speaker 2: listeners realize this, but India is the sixth largest economy
- 13:38Speaker 2: in the entire world, and to make that top ten
- 13:43Speaker 2: is significant in the impact of the health of India's
- 13:47Speaker 2: economy has on the ripple effect of the entire world.
- 13:51Speaker 2: And I didn't realize that I was preparing for our
- 13:55Speaker 2: notes and some of my questions that I had of you.
- 13:58Speaker 5: That's immense.
- 14:00Speaker 2: That's four point one five trillion dollars in domestic product
- 14:07Speaker 2: in the impact and the third largest global economy is India.
- 14:12Speaker 2: When I think of that, I immediately think of the
- 14:16Speaker 2: privately owned pharmacist and pharmacies throughout the country. Talk to
- 14:21Speaker 2: me about what you've noticed about being a pharmacist or
- 14:26Speaker 2: working with pharmacist or people that because for us in
- 14:29Speaker 2: the States, it's the most accessible person of all of
- 14:32Speaker 2: the healthcare providers it's more accessible than the general practitioner
- 14:37Speaker 2: of physicians. It's more accessible than our nurses which are
- 14:42Speaker 2: so they're the number one trusted pharmacists came in second
- 14:46Speaker 2: in trust.
- 14:47Speaker 5: And then I think of India.
- 14:49Speaker 2: So if India is such a huge amount of commerce happening,
- 14:56Speaker 2: let's talk about the individual what kind of relationship. How
- 15:00Speaker 2: does India look at their pharmacist in comparison to other
- 15:04Speaker 2: healthcare providers for accessibility to the need for healthcare?
- 15:09Speaker 4: I think thought you know, what you sir said is
- 15:11Speaker 4: kind of a true for India. Also, it's such a
- 15:16Speaker 4: large geographical spread which we have, you know, from north
- 15:19Speaker 4: to south to east to west, while having the same
- 15:23Speaker 4: time zone where unlike you say, you have multiple times.
- 15:29Speaker 6: Plus.
- 15:29Speaker 4: What we need to understand is that you have a
- 15:31Speaker 4: differential socio economic ecosyst and for them, the pharmacist is
- 15:38Speaker 4: your first point of call. If I am not feeling well,
- 15:43Speaker 4: I will have a pharmacy which is within the one
- 15:47Speaker 4: hundred to two and fifty feets in vicinity of where
- 15:51Speaker 4: I kind of air stake. So that's the that's the
- 15:54Speaker 4: kind of a the strength of where India is. There
- 15:58Speaker 4: is an organization called AIOC which is all India Organization
- 16:02Speaker 4: of Chemistry and Drugs, which is one of the largest
- 16:04Speaker 4: pharmacy network which we have in India. And in my
- 16:10Speaker 4: fifty four years of you know, born and brought up
- 16:13Speaker 4: and being in this part of the world, it was
- 16:16Speaker 4: one of the easiest way for us to go and
- 16:20Speaker 4: have a conversation about your sickness, about your illness, and
- 16:24Speaker 4: they were the people who are able to really guide
- 16:26Speaker 4: you through the whole thing.
- 16:28Speaker 6: And the other thing.
- 16:29Speaker 4: Which has really happened and I'm not sure how much
- 16:31Speaker 4: it's sort of is happening in the US. We now
- 16:36Speaker 4: have laid that to the whole e commerce in the pharmacy,
- 16:40Speaker 4: so you don't need to go to our pharmacist. The
- 16:43Speaker 4: pharmacists had tied up and you have the whole e
- 16:45Speaker 4: commerce like what you have in Amazon. We have a
- 16:47Speaker 4: pharmacy Amazon's here where you just need to upload your
- 16:52Speaker 4: prescription and you are able to get the drugs coming
- 16:59Speaker 4: to your house sometimes and within the thirty minutes. Because
- 17:02Speaker 4: that's how the whole network has been has been set up.
- 17:06Speaker 4: It also allows you to look at between the cost
- 17:10Speaker 4: things because one of the things is that we are
- 17:13Speaker 4: one of the biggest generics a market with the right
- 17:15Speaker 4: kind of the quality. So I can look at a
- 17:20Speaker 4: drug which is off patent.
- 17:23Speaker 6: To sort of.
- 17:23Speaker 4: Say, can I go for this general courses of this
- 17:26Speaker 4: general because there is the cost differential, but coming from
- 17:29Speaker 4: a two good quality Indian informa of manufacturers, and I
- 17:32Speaker 4: can say it costs and that's data is available when
- 17:35Speaker 4: I'm going on my e commerce side of it. So
- 17:38Speaker 4: because as I was saying, you know, access to the
- 17:40Speaker 4: medicine should be a right and it should not therefore
- 17:45Speaker 4: get dependent on the pricing. Everybody should be able to
- 17:49Speaker 4: make it happen. And just to give you an example,
- 17:52Speaker 4: a couple of years back, there was a family person
- 17:54Speaker 4: who was going a kind of a surgery fromcology surgery
- 17:58Speaker 4: in the US from India and you know, be part
- 18:01Speaker 4: of it. And after said he was done, they would
- 18:04Speaker 4: prescribed some drugs and we went to the pharmacistem in
- 18:07Speaker 4: the US, and I think the farmacies were so so
- 18:10Speaker 4: helpful to say you can look at, you know, one
- 18:14Speaker 4: of the possible generics from India which you can sort
- 18:18Speaker 4: of access it here, which was at a much lower
- 18:20Speaker 4: cost because there's an off patent molecule. So for someone
- 18:25Speaker 4: who's coming from a different side of the world, who
- 18:27Speaker 4: is who is kind of not part of the Paer ecosystem.
- 18:32Speaker 4: Having a friendly pharmacist to guide you through some of
- 18:35Speaker 4: these systems becomes a such an important thing, and it
- 18:38Speaker 4: sort of really brings up the whole interconnectedness and understanding
- 18:42Speaker 4: that the world is different in different parts of the
- 18:45Speaker 4: world and you need to therefore converse, encourage and guide accordingly.
- 18:52Speaker 2: There's another subject that is a teaching opportunity to learn
- 18:58Speaker 2: from each other. That is medical tourism, where we have
- 19:03Speaker 2: where we have providers from the States going places from
- 19:07Speaker 2: people from India coming to the States and going to
- 19:10Speaker 2: Africa and different places where there's needs. Talk to us
- 19:14Speaker 2: about your experiences within medical tourism, and also in our
- 19:20Speaker 2: show notes, I'll make sure we put a link in
- 19:22Speaker 2: for people that are listening if they're interested in connecting
- 19:25Speaker 2: with a medical tourism network and group, because there are
- 19:30Speaker 2: listeners that we have who are passionate who would love
- 19:33Speaker 2: an opportunity to travel abroad and become a giver of
- 19:38Speaker 2: their time in working with people who are in desperate needs.
- 19:42Speaker 2: So Gatta Abukawk, who is from New Jersey. She is
- 19:49Speaker 2: a pharmacy owner. She travels the globe and she goes
- 19:52Speaker 2: to some very dangerous places. She was in the Gaza
- 19:55Speaker 2: Strip a year ago when when there was a ton
- 19:58Speaker 2: of fighting going on and she risked her life to
- 20:02Speaker 2: deliver medications specifically for children, and I was just blown away.
- 20:06Speaker 2: Made me cry just to read some of her experiences.
- 20:11Speaker 2: But talk to me about medical tourism and how important
- 20:14Speaker 2: that is.
- 20:16Speaker 4: I think it's kind of an extension of what taught
- 20:19Speaker 4: you and everything the whole interconnected world. Now, if you
- 20:24Speaker 4: have an elective surgery which you would like to undertake, right,
- 20:27Speaker 4: so you want to sort of go for a total
- 20:29Speaker 4: need replacement hypothetically, Now that might be something which if
- 20:36Speaker 4: you go to any system saying in NHS or the US,
- 20:40Speaker 4: you may be getting something which is six months down
- 20:43Speaker 4: the line or nine months down the line. So one
- 20:46Speaker 4: issue is the timelines. You know, when are you getting
- 20:49Speaker 4: excess to a provider to say I'm going to do
- 20:52Speaker 4: this for you nine months down the line so or
- 20:55Speaker 4: twelve months down the line. So there's a queue in
- 20:58Speaker 4: which you are sort of standing to get excess. The
- 21:00Speaker 4: other thing is the cost of making it happen, and
- 21:04Speaker 4: of course each economy operates differently, so the cost is
- 21:07Speaker 4: higher depending on which economy are residing. Now, this is
- 21:11Speaker 4: where the interconnectedness comes in. You can come into stay
- 21:16Speaker 4: in India and you can have an access to the
- 21:21Speaker 4: one of the most advanced medical healthcare provider who can
- 21:27Speaker 4: make this surgery available the next day or you know,
- 21:31Speaker 4: they would build other things thing you come in and
- 21:33Speaker 4: will take care.
- 21:34Speaker 6: Of you the time you lane in India.
- 21:36Speaker 4: Come in, you'll have the best of the doctors, the
- 21:40Speaker 4: top most technologies in alignment with what's available in the
- 21:43Speaker 4: US or any of the global markets. And it will
- 21:47Speaker 4: be done at one fifth or one sixth of the
- 21:51Speaker 4: cost which is there within the timelines which you are
- 21:54Speaker 4: looking for. So you don't need me to wait for
- 21:56Speaker 4: a year, get it done at the one fifth and
- 21:59Speaker 4: one says, So I would sort of say, become more
- 22:02Speaker 4: culturally sensitive to the world outside of where you are assiding.
- 22:07Speaker 4: So it has three plusses which is coming to you.
- 22:11Speaker 6: You know, it's.
- 22:11Speaker 4: Allowing you to ensure that you get relative surgery something
- 22:16Speaker 4: which you don't need to wait, do it at a
- 22:19Speaker 4: cost which is much more lower. Definitely, you know it
- 22:23Speaker 4: may not be paid by your insurance, but insurance as
- 22:26Speaker 4: such is a different thing, but it could be done
- 22:28Speaker 4: with through your out of pocket. Plus you get to
- 22:31Speaker 4: sort of meat and see the people which are very
- 22:33Speaker 4: culturally different, almost on the other side of the world.
- 22:36Speaker 4: So you have a huge learning exercise there. So that's one.
- 22:40Speaker 4: The second is the other way. Now there are issues
- 22:47Speaker 4: which you need a space list with. As I said,
- 22:50Speaker 4: I was saying in the just now we had someone
- 22:53Speaker 4: who needed an oncology it was a rare coins of cancer.
- 22:58Speaker 4: Now that was something which we knew can only happen
- 23:00Speaker 4: in US. So you have to go down. So it's
- 23:05Speaker 4: not a one way street. It's not that you have
- 23:07Speaker 4: to just come in here because the cost is low.
- 23:10Speaker 4: You have to also understand where does the expertise lies
- 23:14Speaker 4: there in a certain cases where it's complex cases, if
- 23:18Speaker 4: it is something which you need a specialist for and
- 23:21Speaker 4: that technology only exists in some other part of the world,
- 23:24Speaker 4: you will have to kind of travel and make it happen.
- 23:28Speaker 4: And I think that really, I think should be the
- 23:30Speaker 4: beauty that the borders should not decide where you go
- 23:34Speaker 4: and get access to the things.
- 23:39Speaker 2: There's an attitude of giving to that, and that's giving
- 23:42Speaker 2: of their time and their expertise and tying into people
- 23:46Speaker 2: that have needs. And we've heard of specialty pharmacy or
- 23:51Speaker 2: specialty side. It's mostly cancer's HIV and the expense. And
- 23:58Speaker 2: now we're seeing people go to Canada, some people are
- 24:02Speaker 2: traveling to Mexico and the cost for the same medication
- 24:09Speaker 2: is drastic and it's it's percentage, you know, thousands of
- 24:13Speaker 2: percentages lower. And the United States is going through a
- 24:18Speaker 2: very volatile time in prescription benefit in prescription differentiation from
- 24:25Speaker 2: other countries that have proven that. And this is just
- 24:31Speaker 2: a matter of education for our listeners. But medications don't
- 24:35Speaker 2: have to be the expensive way that they're you know,
- 24:40Speaker 2: delivered here in the States in in just as effective.
- 24:47Speaker 5: Yes, it's just it's mind blowing.
- 24:50Speaker 2: And and I think that we're learning more about international
- 24:55Speaker 2: connections in curating in you know, the delivery and the
- 25:02Speaker 2: ingredients and the development, and so many of our pharmaceutical
- 25:06Speaker 2: manufacturers are global anyway. So you know, my question is
- 25:11Speaker 2: how do we how do we come up with pricing
- 25:16Speaker 2: and structures that serve India the same way that it
- 25:21Speaker 2: would serve the United States and vice versa, so that
- 25:24Speaker 2: our costs don't crush people. That there's people that are
- 25:28Speaker 2: in the United States that are deciding do I need
- 25:30Speaker 2: my medication or do you need to buy food? And
- 25:33Speaker 2: it's just that's a horrible situation to be listening to you.
- 25:37Speaker 2: But what have you noticed in the contrast between the
- 25:40Speaker 2: United States costs of health care and medications versus other
- 25:45Speaker 2: places throughout the world.
- 25:47Speaker 4: So I think, Todd, if you look at the cost,
- 25:50Speaker 4: the US cost is definitely.
- 25:54Speaker 6: High.
- 25:55Speaker 4: When I say high, it's take really, really high, and
- 25:59Speaker 4: that could really anyone. While you may have access to
- 26:03Speaker 4: the health insurance part of it, while you may have
- 26:06Speaker 4: other peer ecosystem, the basic cost is on a higher side.
- 26:13Speaker 4: Having said that, we also need to recognize the fact
- 26:16Speaker 4: that the US is where the innovation has happening and
- 26:20Speaker 4: there is a kind of a cost. So what we
- 26:22Speaker 4: really need is a balancing and where you do need innovation,
- 26:28Speaker 4: and we need to find a right financing mechanism so
- 26:32Speaker 4: that people can take it access to the innovation. But
- 26:35Speaker 4: innovation may constitute five percent of the medicines or the
- 26:41Speaker 4: medical technologies which you need. The rest of that really
- 26:45Speaker 4: can come in from the other parts of the world,
- 26:48Speaker 4: which again really take the innovation and then bring it
- 26:51Speaker 4: to a more affordable level and supply it back. So
- 26:55Speaker 4: it's an equation which has to have both the It
- 27:01Speaker 4: has to have the innovators and it has to have
- 27:03Speaker 4: the people who can then well the innovation chatter is over,
- 27:09Speaker 4: can really mass produce it and issue that people continue
- 27:12Speaker 4: to have an access to it. So that's really is
- 27:15Speaker 4: with what we really kind of a need to ensure
- 27:20Speaker 4: that we are able to deliver a quality of health
- 27:24Speaker 4: and quality of life which every citizen of this world needs.
- 27:31Speaker 2: A good way of putting it. I've been so excited
- 27:35Speaker 2: to learn from different writers, many of them have been
- 27:40Speaker 2: sourced from medical life. The collection of so many insights
- 27:45Speaker 2: and the connection back to what we do in covering
- 27:51Speaker 2: stories that just don't get enough discussion is quite important.
- 27:57Speaker 2: And there's an organization that we're both aware of that.
- 28:02Speaker 2: I'm very proud that they've grown in the United States
- 28:05Speaker 2: as strong as they have for representation of their members
- 28:09Speaker 2: but serving their communities throughout the country as well as
- 28:13Speaker 2: throughout the world. But I want to give a shout
- 28:15Speaker 2: out to the India Pharmaceutical Alliance and their work over
- 28:21Speaker 2: the years they've worked with me and a team of
- 28:25Speaker 2: people that I've worked with, which is called sweet our X,
- 28:27Speaker 2: which was a pharmacy management system, a software system, And
- 28:32Speaker 2: we've seen their events and we've seen what they're doing.
- 28:36Speaker 2: But Ahmad, these people that run this organization are so
- 28:42Speaker 2: giving of their time every time we asked for some
- 28:45Speaker 2: direction or we ask them for some insights, the giving
- 28:50Speaker 2: of their time and giving of their expertise. And blending
- 28:53Speaker 2: that with the pharmacy owners in the United States who
- 28:57Speaker 2: are Indian or they want that familiarity, they want they
- 29:02Speaker 2: feel like there's trust. But then they once they build
- 29:05Speaker 2: that relationship, they pour that out through their whole their
- 29:08Speaker 2: whole community. And I think that a patient that is
- 29:15Speaker 2: is understanding.
- 29:16Speaker 5: They don't know what's happening behind the scenes.
- 29:18Speaker 2: What they know is the services that they're getting from
- 29:21Speaker 2: their pharmacist. But you've worked with other organizations throughout the world,
- 29:26Speaker 2: and I p A you've known of them as well,
- 29:30Speaker 2: and and I thought that was a special coincidence before
- 29:34Speaker 2: we jumped on on the car.
- 29:36Speaker 4: And somehow we're supposed to take that logic, sah You know,
- 29:41Speaker 4: I P the leadership is someone who I have known
- 29:44Speaker 4: very well, and they really are the ones who are
- 29:49Speaker 4: really bringing the Indian farmer to the global stage. They
- 29:52Speaker 4: are the ones who really are committed to ensure that
- 29:56Speaker 4: the innovation quality and exists in me is kind of
- 30:00Speaker 4: three or three pillars on which they are kind of
- 30:01Speaker 4: really working on and going to do the same thing
- 30:04Speaker 4: that as a pharmastuy of industry. The rule is to
- 30:07Speaker 4: ensure that people get access to the medicine. I remember
- 30:12Speaker 4: a couple of years back they did a campaign is
- 30:13Speaker 4: called Mission Medicine Delivering Life. The whole idea was that
- 30:18Speaker 4: how from the basics of manufacturing to the quality checks
- 30:24Speaker 4: to supply chain, how medicine breaches every household and every
- 30:28Speaker 4: home across the world and that really brings the smile
- 30:32Speaker 4: and the life in the minds of the people. So
- 30:34Speaker 4: from what you sort of said from the giving part,
- 30:36Speaker 4: it's not just a business, it's more about being at
- 30:40Speaker 4: the core of every individual to say here we are
- 30:43Speaker 4: will help you leave the best life which you can lead,
- 30:47Speaker 4: and we are here to support you need it every step.
- 30:51Speaker 5: So what project is on your horizon next? And where
- 30:57Speaker 5: are you going?
- 30:57Speaker 2: Because you shared before we start a record that you
- 31:00Speaker 2: have a trip upcoming.
- 31:03Speaker 4: Yeah, I'm off to the bombit tomorrow morning. And as
- 31:09Speaker 4: is what you sort of brought up is what's happening.
- 31:11Speaker 4: I'm meeting the ip A leadership. You know, I've known
- 31:15Speaker 4: then for for a long period of time and I
- 31:20Speaker 4: was gone planning and I'm sure you to be in
- 31:22Speaker 4: bombit tomorrow, so I took an opportuity to reach out
- 31:25Speaker 4: and I'm looking forward to having some interesting and insightful
- 31:29Speaker 4: conversation with the ip leadership tomorrow.
- 31:31Speaker 5: I'm excited. I'm excited to hear about that.
- 31:33Speaker 2: We'll have to have you back as well as a
- 31:36Speaker 2: team member from the Indian Pharmaceutical Alliance. I want to
- 31:40Speaker 2: thank you, Ahmad for being a guest today on This
- 31:43Speaker 2: Week in Pharmacy, sharing your insights and I just want
- 31:46Speaker 2: to say your work is noticed on a global scale.
- 31:49Speaker 2: So I feel honored to know you and call you
- 31:52Speaker 2: my friend, and we're going to have you back on
- 31:54Speaker 2: tworks very soon.
- 31:56Speaker 4: Thank you, dog, I appreciate having me here.
- 32:07Speaker 1: This episode is sponsored by Independent Pharmacy Cooperative, widely known
- 32:11Speaker 1: as IPC. Established in nineteen eighty three, IPC is the
- 32:14Speaker 1: nation's largest group purchasing organization owned by Independent Pharmacy with
- 32:19Speaker 1: a mission of maximizing the success of community pharmacists. IPC
- 32:23Speaker 1: works to provide members with access to effective programs and
- 32:26Speaker 1: services designed to enhance profitability for independent pharmacy.
- 32:31Speaker 6: Read more about our mission.
- 32:32Speaker 1: By checking out our website at ipcrx dot com. That's
- 32:36Speaker 1: ipcarx dot com.
- 32:52Speaker 2: Welcome back to this Week in Pharmacy. My friend fellow
- 32:55Speaker 2: pittsburgher back on the show, doctor Chris Antipas.
- 32:59Speaker 7: How are you, Chris?
- 33:00Speaker 6: I'm well, my friend. How are you good? Good?
- 33:02Speaker 2: Or recovered from the long weekend? I needed an extra
- 33:07Speaker 2: day because I did a lot of chores, got the
- 33:10Speaker 2: flowers up. But southwestern Pennsylvania is a monsoon right now.
- 33:14Speaker 2: It's just rainy out there.
- 33:16Speaker 6: That's it, I know.
- 33:18Speaker 8: And when it rains here, it just it just rains
- 33:20Speaker 8: and it just doesn't stop raining.
- 33:22Speaker 6: So I guess that's.
- 33:24Speaker 8: The life we live here in southwestern Pa. We're insulated
- 33:28Speaker 8: from all the really bad stuff, but we also struggle
- 33:31Speaker 8: to get the good stuff, so we're always in a
- 33:34Speaker 8: state of discontent with the weather.
- 33:37Speaker 2: Seventy eight days of sunshine is the average for western Pennsylvania.
- 33:42Speaker 7: That's crazy.
- 33:43Speaker 2: I did not know that there was a stat That's
- 33:45Speaker 2: one of my lolo when my daughter's friends brought up
- 33:49Speaker 2: and I'm like seven, So I checked it it came out.
- 33:52Speaker 2: It was like, yeah, you're right, it's seventy eight, seventy
- 33:54Speaker 2: nine days of sunshine.
- 33:56Speaker 7: That's not enough sunshine.
- 33:57Speaker 8: So that in these parts when it is sunnyeople try
- 34:01Speaker 8: to take advantage of it as much as they can.
- 34:02Speaker 8: They're out in their front lawn sunbathing.
- 34:05Speaker 2: That's right, Wow, it's right getting burnt.
- 34:08Speaker 6: Yeah.
- 34:10Speaker 2: So we just got back from Assembia. What a great gathering.
- 34:13Speaker 2: It was just talking to some of my other colleagues
- 34:16Speaker 2: that are preparing for other conferences. We're excited about Idea
- 34:19Speaker 2: Share and possibly going to Thought Spot, going to the
- 34:23Speaker 2: RBC through Cardinal Health obviously this fall, getting ready for NCPA.
- 34:28Speaker 2: But there was something special about SMBIA. We're not talking
- 34:32Speaker 2: about things that we were discussing, say, five years ago.
- 34:38Speaker 2: It seems when we go to Assembia, people are on
- 34:41Speaker 2: the edge. They're always talking about, Hey, what's happening next.
- 34:44Speaker 7: And Modesto and Paragon.
- 34:48Speaker 2: Three sixty had a booth there, very active booth. You
- 34:51Speaker 2: cheated by having the hockey game playing in your booth too,
- 34:56Speaker 2: which was a draw.
- 34:58Speaker 7: I'm have to remember that too, by the way.
- 35:00Speaker 2: But talk to us about your experience at ASSEMBIA and
- 35:03Speaker 2: then I have some questions about Paragons next phase.
- 35:07Speaker 6: Yeah, it was great.
- 35:07Speaker 8: I mean Assembia is as you said, there's always a
- 35:12Speaker 8: very clear.
- 35:15Speaker 6: Sense and it's palpable.
- 35:17Speaker 8: The innovation that's happening in the marketplace, I think it's
- 35:20Speaker 8: largely driven by the fierce competition. Like specially pharmacy, Basically,
- 35:25Speaker 8: everybody's your competitor, and so you have to really fight
- 35:31Speaker 8: for differentiation. You've got to deliver service, and the competition
- 35:37Speaker 8: is so strong, and everybody's got great marketing messages, but
- 35:43Speaker 8: ultimately you've got to kind of prove it. And so
- 35:45Speaker 8: the companies that are still around that have survived to date,
- 35:50Speaker 8: they're I think they're really pushing the boundaries to deliver
- 35:55Speaker 8: an experience or an outcome that differentiates them from the
- 36:00Speaker 8: rest of the field. So I do think that the
- 36:02Speaker 8: fierce competition is what drives a lot of that at
- 36:05Speaker 8: a SEMBIA and a SMBIA has found a way to
- 36:07Speaker 8: channel that to an experience where all of these competitors
- 36:11Speaker 8: can kind of be in the same space. There's obviously
- 36:14Speaker 8: more than just pharmacies there. They are industry folks. There's consultants, obviously,
- 36:19Speaker 8: drug manufacturers and payers, so there's ample opportunities to get
- 36:23Speaker 8: in front of prospects and also partners, current partners and clients.
- 36:29Speaker 6: But yeah, we walked away from there feeling really great.
- 36:33Speaker 8: We kind of it was the unveiling of our newest
- 36:36Speaker 8: technology that we're leveraging with Modesto, and all the conversations
- 36:41Speaker 8: that we had there were very energizing and they were
- 36:45Speaker 8: very positive. We had a chance to show off what
- 36:48Speaker 8: we're doing and people really they really loved it. So
- 36:53Speaker 8: we're feeling great coming out of it. We've had several
- 36:55Speaker 8: follow up conversations already, and the more the more we
- 36:59Speaker 8: kind of show people what we can do and let
- 37:03Speaker 8: them now start to see it and experience it, the
- 37:06Speaker 8: more excited everybody gets, obviously including us.
- 37:09Speaker 6: So it was great.
- 37:09Speaker 8: We're really pumped about the follow up here in the
- 37:12Speaker 8: weeks following a symbia.
- 37:14Speaker 2: So personalization of that care and that care starts out
- 37:20Speaker 2: with shock the you know, someone finding out maybe they
- 37:24Speaker 2: have a disease that they're gonna have to live, they're
- 37:26Speaker 2: gonna have to live with for the rest of their life.
- 37:28Speaker 2: So you wrap your arms around this patient. And that's
- 37:32Speaker 2: how specialty pharmacy is really setting themselves different than other
- 37:37Speaker 2: facets of pharmacy and pharmacy care, and it starts with
- 37:41Speaker 2: that patient's journey, not just the prescription. It's dialing into
- 37:46Speaker 2: how you personalize care. That that personal care team. These
- 37:51Speaker 2: people get to know not only the patient but there
- 37:54Speaker 2: they know their family, they know the dog, they know,
- 37:57Speaker 2: you know, what's.
- 37:58Speaker 7: Going on in these people's lives.
- 37:59Speaker 2: That can indication through maybe texting or email or personalization
- 38:04Speaker 2: or something or follow up. And then the emotional support
- 38:08Speaker 2: that is also tied into how how it can affect
- 38:13Speaker 2: the financial realm of the patient. And then also the
- 38:18Speaker 2: follow up and constant tapping in of how are you feeling,
- 38:21Speaker 2: what's going on? How is this medication if you're tie
- 38:24Speaker 2: trading to maybe a larger dose, smaller dose, different medication.
- 38:29Speaker 2: It's so hands on. People say that and it's like
- 38:32Speaker 2: a buzzword. But boy do I know this more than
- 38:34Speaker 2: ever now, soaking and spending more time with specialty pharmacists.
- 38:39Speaker 2: But expand upon that because Paragon three sixties taking that
- 38:43Speaker 2: to the whole next level.
- 38:44Speaker 8: Yeah, I mean, the stakes are just higher with some
- 38:48Speaker 8: of these medications. They have more serious risks, They have
- 38:52Speaker 8: more complicated dosing considerations, storage requirements, and life is happening
- 39:02Speaker 8: at the same time that you're trying to manage your disease. Right,
- 39:05Speaker 8: So the idea another buzz term of the social determinists
- 39:08Speaker 8: of health, like these are real. The people travel or
- 39:13Speaker 8: they have issues. They may have, you know, financial challenges,
- 39:18Speaker 8: they don't have reliable electricity, or they're in an area,
- 39:21Speaker 8: maybe they don't have refrigerators. I mean, life is happening,
- 39:25Speaker 8: and when you think about your own personal journey, there
- 39:28Speaker 8: are things that happen that you're not quite sure like
- 39:30Speaker 8: what you should be doing in this situation. And so
- 39:33Speaker 8: that's where having your pharmacist be available to you to
- 39:39Speaker 8: be able to kind of support your unique journey and
- 39:43Speaker 8: also have your pharmacist anticipate the challenges that you might
- 39:47Speaker 8: be facing. So as an example, I mean, one of
- 39:50Speaker 8: the therapies we support has a titration schedule, like you
- 39:55Speaker 8: start the dose and then you have to increase the
- 39:58Speaker 8: dose over a period of several weeks. And during this
- 40:01Speaker 8: titration you are just like very likely to experience some
- 40:05Speaker 8: side effects, some unpleasant gi side effects, and we know
- 40:10Speaker 8: this is likely to happen. And so if I'm your pharmacist,
- 40:15Speaker 8: I can simply put a label on the bottle, send
- 40:17Speaker 8: it to you, send you the information offered a counsel.
- 40:20Speaker 8: You're too busy, like you're at the supermarket or you're
- 40:22Speaker 8: at your kids' soccer game. You're like, no, I can't
- 40:25Speaker 8: talk right now. Sorry, No, I'm good. I'll just read
- 40:28Speaker 8: what you send me. I'll read the information. And then
- 40:30Speaker 8: you get this information and you're trying to sort through
- 40:33Speaker 8: it like that could be the experience. You're basically on
- 40:38Speaker 8: your own figuring out this medication. But you have the
- 40:41Speaker 8: instructions there, and if you're competent enough to read it
- 40:44Speaker 8: and you understand it, great, maybe you have a better
- 40:47Speaker 8: shot than most. But in contrast to that, you can
- 40:50Speaker 8: have a pharmacist that is proactively communicating to you and
- 40:56Speaker 8: giving you not a whole bunch of information at once
- 40:59Speaker 8: for you to die, but giving you the relevant information
- 41:03Speaker 8: at the time that you needed. We call this a journey.
- 41:07Speaker 8: You're going on a journey, and at the beginning of
- 41:09Speaker 8: this journey, you're going to have this complicated dosing thing
- 41:12Speaker 8: where you're going to have to take increasing amounts of
- 41:15Speaker 8: the medicine over a matter of weeks. And that journey
- 41:18Speaker 8: also includes some rocky roads. If you will in that
- 41:22Speaker 8: you're going to not feel great, but we expect you
- 41:25Speaker 8: to not feel good for a short period of time.
- 41:28Speaker 8: But if we can get you through that difficult time
- 41:31Speaker 8: where you don't feel good at all, on the other
- 41:34Speaker 8: side of that is the positive outcome that we're fighting
- 41:37Speaker 8: for and what you're suffering for. Basically, we can proactively
- 41:44Speaker 8: communicate at the right time with that patient on their journey.
- 41:49Speaker 8: Their journey begins on whatever Monday to twenty fifth. That's
- 41:54Speaker 8: different than the patients we served last week. And so
- 41:58Speaker 8: when you start multiplying that by large numbers of patients,
- 42:02Speaker 8: it becomes basically impossible to customize this personal journey for
- 42:10Speaker 8: a patient where you deliver the information for them in
- 42:14Speaker 8: a timely manner. And we were faced with this challenge
- 42:17Speaker 8: like how we want to do this stuff, but I
- 42:20Speaker 8: can't actually do it. I can't physically do it. There's
- 42:23Speaker 8: just it's not possible for me to manually do this process.
- 42:26Speaker 8: That's where our technology came in, and that's how that's
- 42:29Speaker 8: how the technology was really born.
- 42:31Speaker 6: We want to be better.
- 42:32Speaker 8: We want to offer this experience that reaches the patient
- 42:36Speaker 8: where they are in their personal journey and help in
- 42:42Speaker 8: every way possible. To make these medications we're dispensing achieve
- 42:48Speaker 8: their desired outcome, So customizing the journey, providing education and
- 42:56Speaker 8: support and getting feedback, soliciting feedback, Hey, how are you
- 43:00Speaker 8: doing today? Like I want to know, because if you're
- 43:03Speaker 8: not doing well, then maybe there's something I can do
- 43:05Speaker 8: to change that. Maybe I can inquire how you're taking
- 43:08Speaker 8: your menage, or maybe you're not storing it correctly, or
- 43:11Speaker 8: maybe if it's another drug we dispense, it's self administered,
- 43:14Speaker 8: maybe you're not injecting it correctly. But I can't determine
- 43:17Speaker 8: that unless I get feedback from you. One of the
- 43:21Speaker 8: other key components of Modesto is that we also can
- 43:23Speaker 8: access medical information and lab values out of the EHR.
- 43:28Speaker 8: So we're creating these custom campaigns. We're educating the patients,
- 43:34Speaker 8: We're soliciting feedback from them. We're providing the right information
- 43:37Speaker 8: at the time that's appropriate, in a bite size amount
- 43:40Speaker 8: that's digestible. We're balancing that against social determinants that we've
- 43:45Speaker 8: evaluated through assessments, Like we ask patients these questions to
- 43:49Speaker 8: see like what's going on, do you have reliable refrigeration,
- 43:53Speaker 8: et cetera, et cetera. Transportation. Some of the drugs we
- 43:56Speaker 8: dispense are office administered. You can't get your drug if
- 43:59Speaker 8: you can't get to the office to get it administered.
- 44:02Speaker 8: So evaluating social determinants, sharing information, receiving feedback from the patient,
- 44:10Speaker 8: matching that up with some of this medical data. That
- 44:13Speaker 8: is what we're trying to accomplish. That's what we've built
- 44:16Speaker 8: with the technology that we're delivering as a pharmacy, and
- 44:20Speaker 8: it's kind of rooted in this notion of specially pharmacy
- 44:22Speaker 8: is different. It's complicated, It truly is scary for patients,
- 44:28Speaker 8: and we have an opportunity to kind of fill the
- 44:31Speaker 8: gaps of the the healthcare system where it is today,
- 44:34Speaker 8: which is I think many of us would agree that
- 44:36Speaker 8: it's not ideal. It's very expensive, and we don't love
- 44:39Speaker 8: the outcomes we're getting. And so as an advocate for
- 44:43Speaker 8: pharmacists in general, I think we have an opportunity here.
- 44:47Speaker 8: We're doubling down on the technology side. But to your point,
- 44:50Speaker 8: like there's a lot going on in specialty and a
- 44:53Speaker 8: lot of opportunity.
- 44:55Speaker 2: I want to return to what you say, because this
- 44:57Speaker 2: bring peaks interest and that is the connection back to
- 45:00Speaker 2: the electronic health record wherever whatever health system that they're
- 45:04Speaker 2: plugged into, that primary care physician who is the specialist
- 45:07Speaker 2: in oncology or whatever it is. When it's two way,
- 45:13Speaker 2: you're extracting getting some information, you're updating what's happening in
- 45:17Speaker 2: real you know, in real time per se, and then
- 45:19Speaker 2: you are you're feeding that back so that the physician
- 45:21Speaker 2: gets an opportunity to read maybe some notes at some
- 45:24Speaker 2: point when they have a visit. Now not only are
- 45:26Speaker 2: they visiting, maybe that visit is thirty days later, sixty
- 45:30Speaker 2: days later or whatever.
- 45:31Speaker 7: Now they read in and your.
- 45:34Speaker 2: Per is is the system also passing information to the
- 45:38Speaker 2: EHR as well.
- 45:40Speaker 8: So our information is we're accessing the information through the
- 45:46Speaker 8: Health Information Exchange and we're pulling data out.
- 45:49Speaker 6: We are also writing.
- 45:51Speaker 8: Back to the Health Information Exchange and that data may
- 45:58Speaker 8: or may not be accessed by the provider, but what
- 46:01Speaker 8: we're doing is we are communicating relevant updates back to
- 46:06Speaker 8: the provider, so we're sending it directly to them. We
- 46:08Speaker 8: can also communicate to the providers into their EHR and
- 46:12Speaker 8: send them messages. So when we have relevant updates or
- 46:15Speaker 8: relevant information, we're sharing that back with the provider. We're
- 46:18Speaker 8: acting somewhat like a triage element, where there are a
- 46:23Speaker 8: lot of things we can handle on our own. If
- 46:25Speaker 8: it's related to the medication and it's an administration issue
- 46:28Speaker 8: or storage or how they're taking or how they're managing
- 46:30Speaker 8: side effects. There are a lot of things that are
- 46:33Speaker 8: well within the purview of the pharmacists to be able
- 46:35Speaker 8: to support and care for the patient directly. But in
- 46:38Speaker 8: cases where we're we identify there's a broader issue or
- 46:41Speaker 8: it requires prescriber intervention, like you know what, we're having
- 46:45Speaker 8: an issue with this therapy, we need to change the dose,
- 46:47Speaker 8: or we don't. You know, we don't advocate necessarily to
- 46:51Speaker 8: just change therapies willy nilly, but sometimes it's not the
- 46:55Speaker 8: appropriate therapy, or maybe there's a drug interaction that we
- 46:57Speaker 8: have to address. By changing therapies, we obviously are going
- 47:01Speaker 8: to get the physician involved, and when we create care
- 47:04Speaker 8: plans for our patients, we're also sharing that with the physician.
- 47:07Speaker 8: So the whole notion of interoperability and sharing of information,
- 47:11Speaker 8: all of that is really critical and important.
- 47:14Speaker 6: And we are in any way, in every way.
- 47:18Speaker 8: Possible, making sure that the providers are involved and engaging
- 47:22Speaker 8: them to help support the patient in whatever situation they're facing.
- 47:28Speaker 7: Let's talk financial for a second.
- 47:30Speaker 2: So what APIs or connections in are is a system
- 47:37Speaker 2: able to coach flag bring up to the patient that hey, hey,
- 47:42Speaker 2: do you ever hear of excessia health or do you
- 47:45Speaker 2: ever hear of this program or do you ever hear
- 47:47Speaker 2: what other ways are we keeping patients adherent based on
- 47:51Speaker 2: the financial strain that's created.
- 47:55Speaker 8: Yeah, So we as a pharmacy, one of our core
- 47:59Speaker 8: services we provide the patients is the financial assistance to
- 48:02Speaker 8: help bridge them to available programs, whether those be manufacture
- 48:06Speaker 8: programs or other foundation programs that are out there. There
- 48:10Speaker 8: are several companies that are provided like that's their focus
- 48:14Speaker 8: is to help provide financial support. But we obviously we
- 48:20Speaker 8: know that our patients if they can't afford their medicine,
- 48:24Speaker 8: then they're definitely not going to get better. And financial
- 48:27Speaker 8: barriers have been a long standing issue, especially in this
- 48:31Speaker 8: industry of specialty pharmacy where you have these really expensive meds.
- 48:34Speaker 6: So we're very mindful of that.
- 48:36Speaker 8: We also attempt to you know, oftentimes health plans have
- 48:40Speaker 8: resources for their members and the members just don't know
- 48:43Speaker 8: about it. So we also in our process of evaluating
- 48:48Speaker 8: how to help support our patients just in doing this
- 48:50Speaker 8: as a specialty pharmacy, we also make sure that we
- 48:54Speaker 8: consider health plan resources that are already available to them.
- 48:59Speaker 8: In Pennsylvania there, you know, there's the PACE program. You
- 49:03Speaker 8: may be familiar with that Pennsylvania Pace. It's funded by
- 49:05Speaker 8: the lottery and there are a ton of people out
- 49:09Speaker 8: there that are eligible for PACE that are they don't
- 49:12Speaker 8: even know about it. And so over my over the
- 49:15Speaker 8: years that I've been doing this, I mean there's countless
- 49:18Speaker 8: patients that we have helped enroll them in available programs
- 49:23Speaker 8: and like PACE. And yeah, it's a big part of
- 49:27Speaker 8: what we do because we recognize it's it's an important consideration.
- 49:32Speaker 8: When you're trying to keep somebody on a therapy that
- 49:34Speaker 8: can't afford it, they're not going to get it. And
- 49:36Speaker 8: we also, you know, we kind of provide additional social
- 49:42Speaker 8: support for patients because.
- 49:43Speaker 6: Sometimes they can't afford food. And so we obviously can't
- 49:46Speaker 6: solve everybody's problems.
- 49:47Speaker 8: They're not they're not a charity so to speak, but
- 49:50Speaker 8: we're mindful of it, and we're trying to bridge paces
- 49:53Speaker 8: through resources that are available to them and where were possible.
- 49:58Speaker 2: So I'm excited about what's coming Modesto, the infrastructure, the
- 50:03Speaker 2: Paragon three sixty sets of time. It's a system that
- 50:07Speaker 2: you've designed as it's moved forward.
- 50:10Speaker 7: I remember were kind of you even been ten years.
- 50:14Speaker 2: Ago, just hearing about the reception, the devices, the technology.
- 50:21Speaker 2: Back to our our listeners, possibly some other pharmacy owners
- 50:26Speaker 2: as well as specially pharmacy operators.
- 50:28Speaker 7: What does the future look.
- 50:30Speaker 2: Like, you know for Modesto as that platform in order
- 50:34Speaker 2: to obviously give Paragon through sixty the needed infrastructure, but
- 50:38Speaker 2: also giving that power to a destructurity pharmacists.
- 50:42Speaker 8: Yeah, we've we've made the decision to explore making Modesto
- 50:49Speaker 8: accessible by other stakeholders. Again, our mission is to help patients,
- 50:57Speaker 8: right everybody. That's I mean, you talked to any pharmacy,
- 51:00Speaker 8: that's what they wanted to do is help patients. Focus
- 51:04Speaker 8: on helping patients and ideally hopefully and it's a struggle
- 51:08Speaker 8: in pharmacy these todays. But build a successful business. That
- 51:11Speaker 8: does that not build a successful business first and foremost,
- 51:15Speaker 8: obviously you need to be successful in order you have
- 51:18Speaker 8: to make money in order to deliver your vision and
- 51:21Speaker 8: your brains and your boys.
- 51:23Speaker 6: But we truly are committed to taking care patients.
- 51:25Speaker 8: We think that we can reach more patients if we
- 51:29Speaker 8: open the access to this innovative technology that we've bold,
- 51:32Speaker 8: So that's what we're doing, and we're working with pharmacies today.
- 51:35Speaker 8: We're talking to some drug manufacturers, to payers, health plans,
- 51:39Speaker 8: various stakeholders that would love to be able to access
- 51:43Speaker 8: the technology, leverage the automation that we've built into it,
- 51:47Speaker 8: the ability to customize these engagements, and the journey having
- 51:51Speaker 8: a rich patient user experience. On the other end of it,
- 51:55Speaker 8: providing the clinical support, the decision support and guidance support
- 52:00Speaker 8: the pharmacist, the clinician. So that's the future. That's what
- 52:03Speaker 8: we're working on doing today. We're rolling that out because
- 52:08Speaker 8: we think that if if we can empower others to
- 52:12Speaker 8: provide this level of care to patients, it's going to
- 52:15Speaker 8: help massive amounts of patients. We have to prove, obviously
- 52:19Speaker 8: that it can do what we say it can do,
- 52:21Speaker 8: but so far, like I mentioned, the excitement around this
- 52:26Speaker 8: idea has been significant. Everybody we talk to and show
- 52:29Speaker 8: this to say how can I use this?
- 52:32Speaker 6: I'd love it? How do I get access to it?
- 52:35Speaker 8: And that's prompted us to really say like, we need
- 52:37Speaker 8: to make this successible to as many as possible. So
- 52:40Speaker 8: that's our vision, that's what we're pushing on, and we're
- 52:43Speaker 8: super excited to see what the rest of this year
- 52:46Speaker 8: and of course what next year brings, because we expect
- 52:49Speaker 8: to have tens of thousands, hundreds of thousands of patients
- 52:53Speaker 8: supported through this technology, which will let us prove and
- 52:57Speaker 8: show the impact that it can actually make.
- 53:01Speaker 2: One of the one of the components of your life
- 53:05Speaker 2: is service, and you're doing that through different sectors of pharmacy.
- 53:09Speaker 2: We know about pastes and the Great South Hills of
- 53:13Speaker 2: the Pittsburgh area, whereas paragone three sixty much more of
- 53:17Speaker 2: a national reach of what you're doing. What else are
- 53:23Speaker 2: you working on that you're passionate about, Chris, that you
- 53:25Speaker 2: can you can share with our listeners.
- 53:28Speaker 8: Yeah, I mean, I'm working on lots of different things
- 53:31Speaker 8: in the in the technology space and the pharmacy care,
- 53:35Speaker 8: you know, actively involved in CPESN and providing direct pharmacist
- 53:40Speaker 8: services and billing, you know, provider pharmacist billing as a
- 53:44Speaker 8: provider services.
- 53:46Speaker 6: I'm very active in.
- 53:48Speaker 8: The self funded employer broker PBM space, trying to generate
- 53:55Speaker 8: some new innovation and disrupt in the space of the
- 54:00Speaker 8: self funded plan to open up access for these commercially
- 54:06Speaker 8: ensured lives, these commercial self funded members, if you will,
- 54:12Speaker 8: to pharmacy services, because they're kind of stuck in this
- 54:14Speaker 8: legacy model of the old way of doing pharmacy. And
- 54:18Speaker 8: so I'm very active in some of the work that
- 54:21Speaker 8: I do in the consulting space with employers to open
- 54:24Speaker 8: up some access there. Right now, what I would say
- 54:28Speaker 8: is that I don't think there's ever been a time
- 54:31Speaker 8: before in healthcare where it has been more ripe for disruption.
- 54:37Speaker 8: Nobody's really satisfied with how things are going, except for
- 54:41Speaker 8: the companies that are these fortune ten, fortune fifty companies
- 54:44Speaker 8: that are making billions of dollars in the system today.
- 54:47Speaker 8: They're good with how it's working because they're making money.
- 54:49Speaker 8: But basically everybody else, providers, especially patients and plan sponsors
- 54:55Speaker 8: and even drug manufacturers to a large extent, they're not satisfied.
- 55:00Speaker 8: So there's so much room for innovation and you know, creativity,
- 55:06Speaker 8: Like I'm leaning heavily into that right now. So everything
- 55:08Speaker 8: I touch, I'm trying to like push the boundaries of
- 55:11Speaker 8: how we do things today, the way we think about.
- 55:13Speaker 6: It and how we could imagine doing it differently.
- 55:16Speaker 8: And so, whether that's on drug procurement and purchasing, whether
- 55:20Speaker 8: that is in clinical care and provider status and the
- 55:25Speaker 8: technology for patient care, pharmacy, dispensing, consulting, et cetera. I'm
- 55:30Speaker 8: trying to put that same energy in all of those
- 55:34Speaker 8: aspects that I touch.
- 55:37Speaker 2: I wanted to thank you for spending time with us
- 55:39Speaker 2: on this week in pharmacy today.
- 55:41Speaker 7: Love what you're doing.
- 55:43Speaker 2: Always love reading about the different journeys that you're on
- 55:47Speaker 2: and the boards of directors that you serve. And I'm like,
- 55:50Speaker 2: oh my goodness, see where where is Chris Antipass Now
- 55:53Speaker 2: It's almost like a finding waldo throughout our industry.
- 55:57Speaker 6: So appreciate you.
- 55:59Speaker 7: Bud, shout you as well. Thank you. I hope you
- 56:02Speaker 7: have a great weekend.
- 56:03Speaker 6: Thanks so much. Talk to you soon.
- 56:05Speaker 7: Hey, we'll be right back.
- 56:06Speaker 1: Feeling lost with the complexities of pharmacy accounting and.
- 56:11Speaker 9: In pharmacy today, there's so many different variables and issues
- 56:17Speaker 9: that impact the pharmacy, books, records, accounting, the profitabilities, so
- 56:20Speaker 9: or so forth. There's different components of pharmacy that have
- 56:23Speaker 9: its own nuances. From an accounting standpoint, and so it's
- 56:27Speaker 9: it's tricky, there's no doubt about it.
- 56:29Speaker 1: Ready to take your pharmacy to the next level, but
- 56:31Speaker 1: don't know where to start. Psychs and Company is here
- 56:34Speaker 1: to help, introducing the RX Assessment. With the RX Assessment,
- 56:39Speaker 1: the pharmacy CPAs and advisors at PSYCHS will do a
- 56:42Speaker 1: deep dive into your accounting and tax situation and give
- 56:45Speaker 1: you the action steps you need to take to take
- 56:48Speaker 1: your pharmacy to the next level.
- 56:50Speaker 9: If you're interested in working with a team who understands
- 56:54Speaker 9: the industry and how the accounting and tax should really
- 56:57Speaker 9: be in a pharmacy, this is This is your chance
- 57:00Speaker 9: to get under the hood check of what's going on
- 57:03Speaker 9: and getting the feedback of any issues or concerns or
- 57:06Speaker 9: again things we think are doing really.
- 57:07Speaker 1: Well with get the financial check up your pharmacy needs
- 57:10Speaker 1: and head over to seikes HYPHENCPA dot com or call
- 57:14Speaker 1: two five to two four eight two seven six four four.
- 57:30Speaker 2: Hey, welcome back to this week in Pharmacy. We have
- 57:34Speaker 2: a special returning guest before I introduced them again, coming
- 57:40Speaker 2: back to twerks, it's allergy season. I was at a
- 57:44Speaker 2: farmer's market recently very near my home literally two miles away.
- 57:51Speaker 2: I picked up some of their honey. I looked at
- 57:54Speaker 2: the honey, where it was, where it was cultivated. It
- 57:56Speaker 2: was a local beehive and cultivator, probably within twenty thirty
- 58:03Speaker 2: miles of my physical address. And there's like that wives
- 58:06Speaker 2: tell out there that like, hey, if you eat local honey,
- 58:09Speaker 2: then it'll help with your local allergies.
- 58:12Speaker 7: And made me.
- 58:13Speaker 2: Think of the subject that we're going to be talking
- 58:15Speaker 2: about today, which is, you know, information and good information
- 58:20Speaker 2: and good resources the best over the counter medicine and
- 58:25Speaker 2: health products from US News and World Report. Excited to
- 58:32Speaker 2: welcome back Shanley Chen. She's senior editor for US News
- 58:39Speaker 2: and Health US News and World Report. I want to
- 58:42Speaker 2: welcome you back, Shanley, to this week in Pharmacy.
- 58:48Speaker 10: Hiks thot, thanks for having me back again.
- 58:50Speaker 5: Happy Friday, Happy Friday.
- 58:53Speaker 2: This is It was a four day week, and it
- 58:56Speaker 2: was nice that we had Memorial Day. But sometimes when
- 58:59Speaker 2: you get an x extra day, it actually makes you
- 59:01Speaker 2: feel more tired because you're just like in that spirit
- 59:05Speaker 2: of relaxing and then it's just like, no, you got
- 59:08Speaker 2: to go to work. So I'm really looking forward to
- 59:10Speaker 2: a recovery weekend from last weekend.
- 59:13Speaker 10: I hear you, I hear you.
- 59:15Speaker 3: I mean it just throws off your entire routine and
- 59:17Speaker 3: your entire schedule, right.
- 59:19Speaker 5: It does, it really does.
- 59:20Speaker 2: So wives tale, eat local honey and it'll help you
- 59:24Speaker 2: with your allergies.
- 59:25Speaker 5: Have you ever heard of that one?
- 59:27Speaker 3: Oh yeah, all the time. I think I even hear
- 59:30Speaker 3: it from my mom. So definitely, definitely, Well, it's true
- 59:34Speaker 3: that in that regard, but I can't necessarily speak to
- 59:37Speaker 3: the validity of it. I'm pretty sure that is definitely
- 59:41Speaker 3: an old wives tale from what I understand the allergist
- 59:45Speaker 3: that I've interviewed, it's not quite this right pollen that
- 59:48Speaker 3: you need in order to build that immunity.
- 59:50Speaker 10: But yeah, I mean, it tastes good.
- 59:52Speaker 5: So it's not your love.
- 59:54Speaker 2: I have to keep telling myself that it's good for
- 59:57Speaker 2: me too. So it's like, or at least in moderation
- 1:00:00Speaker 2: good exactly. Put it in your whatever, your tea or
- 1:00:03Speaker 2: your peanut butter and Julie sandwich, Susie. That's right, all right,
- 1:00:06Speaker 2: So let's share with the pharmacists, in healthcare professionals, our
- 1:00:10Speaker 2: technicians that are out there. They get a lot of
- 1:00:12Speaker 2: questions about over the counter medicines and health products. I
- 1:00:17Speaker 2: know from just listening to people in my own circles,
- 1:00:23Speaker 2: people that I've worked with, people that are my family friends,
- 1:00:27Speaker 2: that over the counter products are perceived to be not hey,
- 1:00:33Speaker 2: this isn't harmful because it's over the counter, and blah
- 1:00:35Speaker 2: blah blah. So every time this report comes out, I'm
- 1:00:37Speaker 2: always sharing it with my personal network because I want
- 1:00:41Speaker 2: them to realize, thank you, medication is medication, and we
- 1:00:46Speaker 2: have to break this down. So share with us and
- 1:00:49Speaker 2: share with our listeners about the latest report.
- 1:00:52Speaker 4: Yeah.
- 1:00:52Speaker 3: Absolutely, So this is our fourth year doing our best
- 1:00:55Speaker 3: OTC and medicine and health products rankings, and we rank
- 1:00:59Speaker 3: nearly nine hundred brands across one hundred and twenty eight categories,
- 1:01:03Speaker 3: including allergy medicine. So if you need an allergy medicine,
- 1:01:07Speaker 3: whether it's you know, allergy eye drops, nasal sprays, or
- 1:01:11Speaker 3: oral decongestins, We've got you covered there. Even vitamins and sunscreens,
- 1:01:16Speaker 3: wrinkle creams. You know, this ranking really runs the gamut
- 1:01:19Speaker 3: of the different categories that you would encounter when you're
- 1:01:22Speaker 3: going into your local pharmacy, when you're going into your
- 1:01:25Speaker 3: local drug store and just walking through those seemingly endless
- 1:01:29Speaker 3: aisles of different brands and products, and so to accomplish this,
- 1:01:34Speaker 3: you know, it's one hundred and twenty eight categories. You know,
- 1:01:37Speaker 3: that is a lot of categories of different products and so,
- 1:01:41Speaker 3: but I'm not the expert here. You know, we relied
- 1:01:44Speaker 3: on the experts of pharmacists the dermatologists to evaluate these
- 1:01:48Speaker 3: brands based on their performance, their safety, and their efficacy.
- 1:01:53Speaker 3: And we rallied five hundred of these across the country
- 1:01:57Speaker 3: to really dig into our extensive list and the different
- 1:02:01Speaker 3: products that are available, and we wanted to make sure
- 1:02:04Speaker 3: that you know, this is a billion dollars, a multi
- 1:02:07Speaker 3: billion dollar industry. People are spending a lot of money
- 1:02:11Speaker 3: on you know, they're different supplements, like you know, multi
- 1:02:16Speaker 3: vitamins for their kids, there multi vitamins for themselves or
- 1:02:20Speaker 3: their loved ones, or even things like allergy.
- 1:02:23Speaker 10: Medicines, you know, and even hearing aids.
- 1:02:26Speaker 3: You know, there are a lot of over the counter products.
- 1:02:30Speaker 10: That are available to consumers.
- 1:02:32Speaker 4: They be so.
- 1:02:33Speaker 3: Easy to be inundated by all the different choices. And
- 1:02:37Speaker 3: of course, you know what because supplements are not FDA regulated,
- 1:02:42Speaker 3: or rather they're not regulated by the FDA the same
- 1:02:44Speaker 3: way that it regulates over the counter drugs. You know,
- 1:02:48Speaker 3: there's there's a lot of there's a huge need to
- 1:02:53Speaker 3: rely on our experts or guidance, and this.
- 1:02:55Speaker 10: Is what we did.
- 1:02:57Speaker 2: I love it, and now also like how you break
- 1:02:59Speaker 2: it down for the consumers to really understand from an
- 1:03:02Speaker 2: educational perspective of the importance of asking your physician and
- 1:03:07Speaker 2: your pharmacists about different things when you select an OTC medicine,
- 1:03:11Speaker 2: and something that the World Report puts out there is
- 1:03:15Speaker 2: reading the label, closely checking the active ingredients, and not
- 1:03:19Speaker 2: exceeding recommended dose allowances. There have been a lot of
- 1:03:23Speaker 2: pharmacists who are getting very big and very influential. We've
- 1:03:28Speaker 2: covered several of them over the years on TikTok, and
- 1:03:33Speaker 2: they're using their pharmacological backgrounds to suggest things. And I
- 1:03:38Speaker 2: really like how you're supportive to both sides of the fence.
- 1:03:42Speaker 2: You're supportive to the providers and you're supportive to the consumer.
- 1:03:46Speaker 2: Talk to me about that balance and how you guys
- 1:03:49Speaker 2: are pushing this information out.
- 1:03:51Speaker 6: Yeah.
- 1:03:51Speaker 3: Absolutely, And to your point, you know that you brought
- 1:03:54Speaker 3: up earlier just because it says it's an over the
- 1:03:57Speaker 3: counter drug does not make it inherently safe. You know,
- 1:04:00Speaker 3: it goes through a very vigorous FDA approval process to
- 1:04:05Speaker 3: make sure that it is safe and effective because they are,
- 1:04:07Speaker 3: at the end of the day, still drugs.
- 1:04:09Speaker 10: The allergy medicines.
- 1:04:10Speaker 3: Or you know, headache and migraine pain relievers and even
- 1:04:17Speaker 3: diarrhea medicines. It really runs the gamut here, but all
- 1:04:20Speaker 3: of these are still drugs and they still do have
- 1:04:23Speaker 3: you know, different drug interactions, side effects, things like that.
- 1:04:27Speaker 3: So we have to really make sure that consumers and
- 1:04:29Speaker 3: our readers know that there are you know, safety issues
- 1:04:34Speaker 3: with with mixing different drugs, and we want to avoid
- 1:04:38Speaker 3: certain drug interactions, whether it's food drug interactions or drug
- 1:04:41Speaker 3: drug interactions. This is absolutely something that we wanted to
- 1:04:47Speaker 3: unpack and that's why we relied on our pharmacystem dermatologists
- 1:04:51Speaker 3: to look into what are the different side effects of
- 1:04:55Speaker 3: syz drug, you know, whatever over the counter product we're
- 1:04:59Speaker 3: looking at alongside the benefits, you know, what are the.
- 1:05:03Speaker 10: Proven health benefits of.
- 1:05:06Speaker 3: These of these products that we're ranking or these brands
- 1:05:08Speaker 3: that we're ranking. But let's also make sure that people
- 1:05:11Speaker 3: know what the potential side effects are, what potential safety
- 1:05:15Speaker 3: considerations as well as what are the different drug interactions
- 1:05:20Speaker 3: and side effects these things could carry.
- 1:05:23Speaker 2: I also like that you're engaging over five hundred independent
- 1:05:28Speaker 2: community pharmacists out there are dermatologists out there, and I'm
- 1:05:33Speaker 2: seeing much more collaboration between pharmacists and dermatologists. Talk to
- 1:05:38Speaker 2: us about the selection in some of the organizations and
- 1:05:42Speaker 2: and pharmacy owners that you're that you're working with.
- 1:05:45Speaker 3: Yeah, absolutely, And so we partner with the Harris Bole
- 1:05:47Speaker 3: who is you know, renowned for running surveys, and we
- 1:05:53Speaker 3: partnered with them in order to conduct these surveys of
- 1:05:57Speaker 3: our five hundred pharmacists and dermatologists, and and they're really
- 1:06:01Speaker 3: across the country and so they're the ones who are
- 1:06:03Speaker 3: seeing the patients who are dealing with these conditions, you know,
- 1:06:07Speaker 3: day in and day out. They're the ones with the expertise,
- 1:06:10Speaker 3: and so we're really relying on them to unpack and
- 1:06:15Speaker 3: explain what the health benefits are, what the side effects are,
- 1:06:19Speaker 3: you know, how to best take a medication, things like that,
- 1:06:24Speaker 3: or even when it comes to hair care, well, what
- 1:06:26Speaker 3: are the benefits of hair growth supplements? You know, what
- 1:06:30Speaker 3: are some of the main ingredients and key ingredients that
- 1:06:32Speaker 3: we should be looking for when we're going through all
- 1:06:35Speaker 3: of these things.
- 1:06:37Speaker 10: So again, I think because the.
- 1:06:39Speaker 3: Health and wellness industry is absolutely just exploding, you know,
- 1:06:45Speaker 3: it's constantly changing and evolving seemingly every year, almost even
- 1:06:49Speaker 3: month to month.
- 1:06:51Speaker 10: You know, That's.
- 1:06:51Speaker 3: Why that's why we really relied on them, but also
- 1:06:55Speaker 3: why we added eleven new categories to reflect all of
- 1:06:59Speaker 3: the different consumer trons.
- 1:07:02Speaker 2: We have several podcasts that start to get really into
- 1:07:06Speaker 2: the weeds with a specific issue pediatrics, sexual health, women's
- 1:07:12Speaker 2: health specifically, there's a women's health products section that breaks
- 1:07:16Speaker 2: into fertility and menopause and prenatal vitamins. This is important
- 1:07:21Speaker 2: for our consumers to understand that.
- 1:07:24Speaker 5: Quite a difference.
- 1:07:25Speaker 2: And even there's lots of pharmacists now who are getting
- 1:07:29Speaker 2: into contraception and they're starting to give guidance. And the
- 1:07:31Speaker 2: reason is is there have been planned parenthood centers that
- 1:07:35Speaker 2: have been shut down throughout the entire country in different
- 1:07:39Speaker 2: reasons for different funding issues. So I think this women's
- 1:07:43Speaker 2: health section in and of itself is extremely important for
- 1:07:46Speaker 2: our pharmacists to understand. You have accessible information through US
- 1:07:51Speaker 2: News and World Report, and I'm definitely going to put
- 1:07:54Speaker 2: a link into this.
- 1:07:56Speaker 3: Awesome thank you no and it's not just accessible information,
- 1:07:59Speaker 3: it's expert backed information too, and most of yeah, and
- 1:08:03Speaker 3: written by our experts as well. I mean, I'm glad
- 1:08:05Speaker 3: you highlighted women's health because for a very long time
- 1:08:08Speaker 3: it's been overlooked. But now I think with the industry
- 1:08:13Speaker 3: finally recognizing the importance of you know, marketing to consumers
- 1:08:17Speaker 3: and providing consumers with products that are directed towards women
- 1:08:23Speaker 3: and that address women's health issues, I think it's just
- 1:08:26Speaker 3: you know, something that we absolutely need. But you know,
- 1:08:28Speaker 3: to your point, we have, you know, fertility supplements. We
- 1:08:32Speaker 3: rank menopause supplements as well as the natal vitamins. But
- 1:08:36Speaker 3: on the other end, we also ranked to stosterone supplements
- 1:08:40Speaker 3: as well for.
- 1:08:40Speaker 5: Men excellent, excellent.
- 1:08:43Speaker 2: So give our listeners any additional guidance to the to
- 1:08:48Speaker 2: the report, anything else that you'd like to mention so
- 1:08:52Speaker 2: that they know that they have information accessible to them,
- 1:08:56Speaker 2: anything you want to share.
- 1:08:57Speaker 3: Absolutely, I mean when you go to the website, which
- 1:08:59Speaker 3: I sure you will link out to.
- 1:09:02Speaker 6: There.
- 1:09:03Speaker 3: There again, there are one hundred and twenty eight categories there.
- 1:09:06Speaker 3: We cover so a wide ranging a number of different
- 1:09:12Speaker 3: categories from hair care, allergies, you know, brain health, sleep, sleep, medications,
- 1:09:17Speaker 3: whether it's over the counter sleep drugs or natural sleep
- 1:09:21Speaker 3: aids like melatonin and magnesium all the way to you.
- 1:09:24Speaker 10: Know, diabetic tools.
- 1:09:25Speaker 3: So there are tons of different products to really address
- 1:09:29Speaker 3: whatever needs you're looking for.
- 1:09:30Speaker 10: So aside from just browsing that.
- 1:09:32Speaker 3: Page, you know, you can just drop in a keyword
- 1:09:35Speaker 3: and it'll pop up exactly right over there and uh
- 1:09:40Speaker 3: and you'll be able to find whatever product category you're
- 1:09:43Speaker 3: looking for. Again, I mean, I think with the hair
- 1:09:47Speaker 3: and hair care and hair growth industry becoming even more popular,
- 1:09:51Speaker 3: that's something that we expanded on as well. So there
- 1:09:54Speaker 3: are tons of different different avenues for you to look
- 1:09:57Speaker 3: at when it comes to your health and wellness schools.
- 1:10:00Speaker 6: I love it.
- 1:10:00Speaker 3: I think another thing to add too is, you know,
- 1:10:03Speaker 3: when consumers are navigating this page, or rather navigating this
- 1:10:07Speaker 3: health and wellness industry, you know, our our ranking is
- 1:10:12Speaker 3: incredibly robust.
- 1:10:13Speaker 10: Like we do a lot.
- 1:10:14Speaker 3: Of work to make sure that our readers and our
- 1:10:18Speaker 3: consumers get the best, highest quality, expert backed information out there.
- 1:10:23Speaker 3: And that's why we provide all these rankings, Like we
- 1:10:25Speaker 3: want to be the first step for them when they're
- 1:10:29Speaker 3: shopping online or you know, in stores, but at the
- 1:10:33Speaker 3: end of the day. You know, we want to make
- 1:10:35Speaker 3: sure to also emphasize the point that you know, these
- 1:10:38Speaker 3: are these are our experts recommendations.
- 1:10:40Speaker 10: There are topics, but.
- 1:10:42Speaker 3: If you ever have any questions, you know, please talk
- 1:10:44Speaker 3: to your doctor, talk to your pharmacist.
- 1:10:47Speaker 5: Thank you, I love it, Chanley. This is so good
- 1:10:50Speaker 5: to have you back.
- 1:10:51Speaker 2: You have an open door opportunity to come on twerks
- 1:10:55Speaker 2: and share information. We can get some of your pharmacist
- 1:10:58Speaker 2: friends on and we can drill down into some of
- 1:11:00Speaker 2: these subjects. But thanks so much for being on twerks again.
- 1:11:04Speaker 10: Oh thanks so much for having me. It's been a blast.